ACE inhibitor therapy could be beneficial for many patients with hypertension

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.245, 2000-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Compliance, Persistence, Healthcare Resource Use, and Treatment Costs Associated with Aliskiren plus ARB versus ACE Inhibitor plus ARB Combination Therapy: In US Patients with Hypertension

By Chang Joanne

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 1, 2011-02 ,pp. : 21-32

Adis International

Access to resources Recommend Favorite

The addition of a β-blocker to regular ACE inhibitor therapy improves functional status in patients with chronic heart failure

Inpharma, Vol. 1, Iss. 1558, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

ACE inhibitors not worth it as first-line therapy in hypertension

Inpharma, Vol. 1, Iss. 1388, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

ACE inhibitors not worth it as first-line therapy in hypertension

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 413, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

ACE inhibitor therapy appears to be cost effective in HF

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 362, 2002-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite